                   AIDS INFORMATION NEWSLETTER
                   Michael Howe, MSLS, Editor
                     AIDS Information Center
                VA Medical Center, San Francisco
                     (415) 221-4810 ext 3305
                          June 30, 1995

               Opportunistic Infections (Part III)

         Bibliography of OI Review Articles - Section B

[Editor's Note:  This is the second of three parts of a
bibliography that includes references for review articles for
opportunistic infections.]


IV. INFECTIONS - MYCOBACTERIAL

A. MYCOBACTERIUM AVIUM COMPLEX (MAC)

     1.   Benson C. Disseminated Mycobacterium avium Complex
          Disease in Patients with AIDS. AIDS Research and Human
          Retroviruses. 1994;10(8):913-916.

     2.   Benson CA. Ellner JJ. Mycobacterium avium Complex
          Infection and AIDS: Advances in Therory and Practice.
          Clinical Infectious Diseases. 1993;17:7-20.

     3.   Chaisson RE. Benson CA. Dube MP. et al. Clarithromycin
          Therapy for Bacteremic Mycobacterium avium Complex
          Disease. Annals of Internal Medicine. 1994;121(12):905-
          911.

     4.   Dautzenberg B. Truffot C. Legris S. Activity of
          Clarithromycin against Mycobacterium avium Infection in
          Patients with the Acquired Immune Deficiency Syndrome:
          A Controlled Clinical Trial. American Review of
          Respiratory Disease. 1991;144:564-9.

     5.   Inderlied CB. Kemper CA. Bermudez LE. The Mycobacterium
          avium Complex. Clinical Microbiology Reviews. 1993
          July;6(3):266-310.

     6.   Maddix DS. Tallian KB. Mead PS. Rifabutin: A Review with
          Emphasis on its Role in the Prevention of Disseminated
          Mycobacterium avium Complex Infection. Annals of
          Pharmacotherapy. 1994;28:1250-54.

     7.   Nightingale SD. Cameron WD. Gordin FM. et al. Two
          Controlled Trials on Rifabutin Prophylaxis Against
          Mycobacterium avium Complex Infection in AIDS. New
          England Journal of Medicine. 1993 Sept;329(12):828-33.

     8.   Northfelt DW. Mycobacterium avium Complex Infection in
          AIDS: Clinical Presentation, Diagnosis, and Current
          Therapy. AIDS Reader. 1993;3(2):40-6.

     9.   Peloquin CA. Controversies in the Management of
          Mycobacterium avium Complex Infection in AIDS Patients.
          Annals of Pharmacotherapy. 1993 27:928-37.

     10.  Recommendations on Prophylaxis and Therapy for
          Disseminated Mycobacterium avium Complex Disease in
          Patients Infected with the Human Immunodeficiency Virus.
          New England Journal of Medicine. 1993 Sept;329(12):898-
          904.

     11.  Rifabutin. The Medical Letter on Drugs and Terapeutics.
          1993;35(Issue 895):36-8.

     12.  Rubin DS. Rahal JJ. Mycobacterium-avium Complex.
          Infectious Disease Clinics of North America.
          1994;8(2):413-426.

B. TUBERCULOSIS

     1.   Barnes PF. Barrows SA. Tuberculosis in the 1990s. Annals
          of Internal Medicine. 1993;119:400-10.

     2.   Centers for Disease Control and Prevention. Initial
          Therapy for Tuberculosis in the Era of Multidrug
          Resistance: Recommendations of the Advisory Council for
          the Elimination of Tuberculosis. MMWR. 1992 May 21;42(No.
          RR-7):[inclusive page numbers].

     3.   Centers for Disease Control and Prevention. Management
          of Persons Exposed to Multidrug-Resistant Tuberculosis.
          MMWR. 1992 Jun 19;41(No. RR-11):61-71.

     4.   Cohn DL. Treatment and Prevention of Tuberculosis in HIV-
          Infected Persons. Infectious Disease Clinics of North
          America. 1994;8(2):399-412.

     5.   Colditz GA. Brewer TF. Berkey CS. et al. Efficacy of BCG
          Vaccine in the Prevention of Tuberculosis: Meta-Analysis
          of the Published Literature. JAMA. 1994;271(9):698-702.

     6.   Drugs for Tuberculosis. The Medical Letter on Drugs and
          Therapeutics. 1992;34(Issue 863):10-12.

     7.   Houston S. Fanning A. Current and Potential Treatment of
          Tuberculosis. Drugs. 1994;48(5):689-708.

     8.   Jacobs RF. Multiple-Drug-Resistant Tuberculosis. Clinical
          Infectious Diseases. 1994;19:1-10.

     9.   Mycobacterial Diseases in HIV Infection. AIDSFILE.
          1992;6(4):[pages inclusive].

     10.  Peloquin CA. Berning SE. Infection Caused by
          Mycobacterium Tuberculosis. Annals of Pharmacotherapy.
          1994;28:72-83.

     11.  Riley LW. Drug-Resistant Tuberculosis. Clinical
          Infectious Diseases. 1993;17(Suppl 2):S442-6.

     12.  Small PM. Shafer RW. Hopewell PC. et al. Exogenous
          Reinfection with Multidrug-Resistant Mycobacterium
          Tuberculosis in Patients with Advanced HIV Infection. New
          England Journal of Medicine. 1993 Apr 22;328(16):1137-
          44.

V.  Infections - Parasitic

A. Review Articles - General

     1.   Drugs for Parasitic Infections. The Medical Letter on
          Drugs and Therapeutics. 1993; 35(Issue 911):111-22.

     2.   Parasitic Diseases in HIV Infection. AIDSFILE.
          1994;8(3):[pages inclusive].

B. CRYPTOSPORIDIOSIS

     1.   Bissuel F. Cotte L. Rabodonirina M. et al. Paromomycin:
          An Effective Treatment for Cryptosporidial Diarrhea in
          Patients with AIDS. Clinical Infectious Diseases.
          1994;18:447-449.

     2.   Fichtenbaum CJ. Ritchie DJ. Powderly WG. Use of
          Paromomycin for Treatment of Cryptosporidiosis in
          Patients with AIDS. Clinical Infectious Diseases. 1993
          Feb;16:298-300.

     3.   Lecuit M. Oksenhendler E. Sarfati C. Use of Albendazole
          for Disseminated Microsporidian Infection in a Patient
          with AIDS. Clinical Infectious Diseases. 1994;19:332-
          333.

     4.   Mannheimer SB. Soave R. Protozoal Infections in Patients
          with AIDS: Cryptosporidiosis, Isosporiasis,
          Cyclosporiasis, and Microsporidiosis. Infectious Disease
          Clinics of North America. 1994;8(2):483-498.

     5.   Petersen C. Cryptosporidiosis in Patients Infected with
          the Human Immunodeficiency Virus. Clinical Infectious
          Diseases. 1992;15:903-9.

     6.   Soave R. Cryptosporidium in HIV Infection. AIDS Reader.
          1993 Jan/Feb;3(1):29-32.

     7.   Soave R. Treatment Strategies for Cryptosporidiosis.
          Annals of the New York Academy of Sciences. 1990;616:442-
          50.

     8.   White AC. Chappell CL. Hayat CS. Paromomycin for
          Cryptosporidiosis in AIDS: A Prospective, Double-Blind
          Trial. Journal of Infectious Diseases. 1994;170:419-24.

C. PNEUMOCYSTIS CARINII PNEUMONIA

     1.   Dohn MN. Weinberg WG. Torres RA. et al. Oral Atovaquone
          Compared with Intravenous Pentamidine for Pneumocystis
          carinii Pneumonia in Patients with AIDS. Annals of
          Internal Medicine. 1994;121:174-180.

     2.   Girard PM. Landman R. Gaudebout C. et al. Dapsone-
          Pyrimethamine Compared with Aerosolized Pentamidine as
          Primary Prophylaxis Against Pneumocystis carinii
          Pneumonia and Toxoplasmosis in HIV Infection. New England
          Journal of Medicine. 1993 May;328(21):1514-20.

     3.   Haile LG. Flaherty JF. Atovaquone: A Review. Annals of
          Pharmacotherapy. 1993 Dec;27:1488-94.

     4.   Hughes W. Leoung G. Kramer F. et al. Comparison of
          Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole
          to Treat Pneumycystis carinii Pneumonia in Patients with
          AIDS. New England Journal of Medicine. 1993
          May;328(21):1521-7.

     5.   Kovacs JA. Masur H. Prophylaxis for Pneumocystis carinii
          Pneumonia in Patients Infected with Human
          Immunodeficiency Virus. Clinical Infectious Diseases.
          1992;14:1005-9.

     6.   Lee BL. Medina I. Benowitz NL. Dapsone, Trimethoprim, and
          Sulfamethoxazole Plasma Levels during Treatment of
          Pneumocystis Pneumonia in Patients with the Acquired
          Immunodeficiency Syndrome (AIDS): Evidence of Drug
          Interactions. Annals of Internal Medicine. 1989;110:606-
          11.

     7.   Masur H. Prevention and Treatment of Pneumocystis
          Pneumonia. New England Journal of Medicine. 1992 Dec
          24;327(26):1853-60.

     8.   Miller RF. Mitchell DM. AIDS and the Lung: Update 1992.
          1. Pneumocystis carinii Pneumonia. Thorax. 1992
          Apr;47(4):305-14.

     9.   Moe AA. Hardy WD. Pneumocystis carinii Infection in the
          HIV-Seropositive Patient. Infectious Disease Clinics of
          North America. 1994;8(2):331-364.

     10.  Recommendations for Prophylaxis Against Pneumocystis
          carinii Pneumonia for Adults and Adolescents Infected
          with Human Immunodeficiency Virus. MMWR. 1992:41(No. RR-
          4):1-11.

     11.  Recommendations for Prophylaxis Against Pneumocystis
          carinii Pneumonia for Persons with Human Immunodeficiency
          Virus. Journal of AIDS. 1993;6:46-55.

     12.  Safrin S. New Developments in the Management of
          Pneumocystis carinii Disease. In: AIDS Clinical Review
          1993/1994. New York: Marcel Dekker, Inc., 1994;95-112.

     13.  Sattler FR. Frame P. Davis R. et al. Trimetrexate with
          Leucovorin versus Trimethoprim-Sulfamethoxazole for
          Moderate to Severe Episodes of Pneumocystis carinii
          Pneumonia in Patients with AIDS: A Prospective,
          Controlled Multicenter Investigation of the AIDS Clinical
          Trials Group Protocol 029/031. Journal of Infectious
          Diseases. 1994;170:165-72.

     14.  Sistek CJ. Wordell CJ. Hauptman SP. Adjuvant
          Corticosteroid Therapy for Pneumocystis carinii Pneumonia
          in AIDS Patients. Annals of Pharmacotherapy. 1992
          Sept;26:1127-33.

     15.  Toma E. Fournier S. Dumont M. et al.
          Clindamycin/Primaquine Versus Trimethoprim-
          Sulfamethoxazole as Primary Therapy for Pneumocystis
          carinii Pneumonia in AIDS: A Randomized, Double-Blind
          Pilot Trial. Clinical Infectious Diseases. 1993;17:178-
          84.

D. TOXOPLASMOSIS

     1.   Availability of Sulfadiazine -- United States. MMWR.
          1992;41(50):950-1.

     2.   Dannemann B. McCutchan A. Israelski D. Treatment of
          Toxoplasmic Encephalitis in Patients with AIDS: A
          Randomized Trial Comparing Pyrimethamine plus Clindamycin
          to Pyrimethamine plus Sulfadiazine. Annals of Internal
          Medicine. 1992;116(1):33-43.

     3.   Gellin BG. Soave R. Coccidian Infections in AIDS:
          Toxoplasmosis, Cryptosporidiosis, and Isosporiasis.
          Medical Clinics of North America. 1992 Jan;76(1):205-
          34.

     4.   Kovacs JA and the NIAID-Clinical Center Intramural AIDS
          Program. Efficacy of Atovaquone in Treatment of
          Toxoplasmosis in Patients with AIDS. Lancet. 1992 Sept
          12;340:637-8.

     5.   Luft BJ. Hafner R. Korzun AH. et al. Toxoplasmic
          Encephalitis in Patients with the Acquired
          Immunodeficiency Syndrome. New England Journal of
          Medicine. 1993 Sept;329(14):995-1000.

     6.   Mariuz P. Bosler EM. Luft BJ. Toxoplasmosis in
          Individuals with AIDS. Infectious Disease Clinics of
          North America. 1994;8(2):365-381.

     7.   Moorthy RS. Smith RE. Rao NA. Progressive Ocular
          Toxoplasmosis in Patients with Acquired Immunodeficiency
          Syndrome. American Journal of Opthalmology. 1993
          Jun;115(6):742-7.

     8.   Masur H. Polis MA. Tuazon CU. et al. Salvage Trial of
          Trimetrexate-Leucovorin for Treatment of Cerebal
          Toxoplasmosis in Patients with AIDS. Journal of
          Infectious Diseases. 1993 June;167:1422-6.

     9.   Pauwels A. Meyohas MC. Eliaszewicz M. et al. Toxoplasma
          Colitis in the Acquired Immunodeficiency Syndrome.
          American Journal of Gastroenterology. 1992;87(4):518-9.

     10.  Pomeroy C. Filice GA. Pulmonary Toxoplasmosis: A Review.
          Clinical Infectious Diseases. 1992 Apr;14:863-70.

     11.  Porter ST. Sande MA. Toxoplasmosis of the Central Nervous
          System in the Acquired Immunodeficiency Syndrome. New
          England Journal of Medicine. 1992;327(23):1643-8.

     12.  Schnapp LM. Geaghan SM. Campagna A. et al. Toxoplasma
          gondii Pneumonitis in Patients Infected with the Human
          Immunodeficiency Virus. Archives of Internal
          Medicine;1992 May;152:1073-7.

     13.  St. Georgiev V. Management of Toxoplasmosis. Drugs.
          1994;48(2):179-188.
